Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Neal-Perry

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Impaired folliculogenesis and ovulation in older reproductive aged womenNanette Santoro, Barbara Isaac, Genevieve Neal-Perry, et al.
Contraception|March 17, 2023
Single-visit insertion of long-acting reversible contraception in a single health systemGretchen S Stuart, Lindsey Yates, Johanna Crump, et al.
Maturitas|November 19, 2025
Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysisMarla Shapiro C M, Genevieve Neal-Perry, Petra Stute, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 27, 2026
Disparities in Genetic Testing: Evaluation of Reproductive Carrier Screening in the United StatesSheetal Parmar, Jessica L Saben, Madeleine Armer-Cabral, et al.
Sleep|June 3, 2021
Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysisKaren A Matthews, Laisze Lee, Howard M Kravitz, et al.
Obstetrics and Gynecology|March 10, 2023
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled TrialGenevieve Neal-Perry, Antonio Cano, Samuel Lederman, et al.
Maturitas|April 30, 2018
Religiosity and faith in relation to time to metabolic syndrome for Hispanic women in a multiethnic cohort of women-Findings from the Study of Women's Health Across the Nation (SWAN)Amanda A Allshouse, Nanette Santoro, Robin Green, et al.
Menopause (New York, N.Y.)|December 4, 2019
Daily luteal serum and urinary hormone profiles in the menopause transition: Study of Women's Health Across the NationNanette Santoro, Samar R El Khoudary, Alexis Nasr, et al.
Environmental Epidemiology (Philadelphia, Pa.)|June 20, 2019
Ambient Air Pollution Exposure and Fecundability in Women Undergoing In Vitro FertilizationSabah M Quraishi, Paul C Lin, Kevin S Richter, et al.
Lancet (London, England)|March 16, 2023
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled studySamuel Lederman, Faith D Ottery, Antonio Cano, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Impaired folliculogenesis and ovulation in older reproductive aged womenNanette Santoro, Barbara Isaac, Genevieve Neal-Perry, et al.
Contraception|March 17, 2023
Single-visit insertion of long-acting reversible contraception in a single health systemGretchen S Stuart, Lindsey Yates, Johanna Crump, et al.
Maturitas|November 19, 2025
Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysisMarla Shapiro C M, Genevieve Neal-Perry, Petra Stute, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 27, 2026
Disparities in Genetic Testing: Evaluation of Reproductive Carrier Screening in the United StatesSheetal Parmar, Jessica L Saben, Madeleine Armer-Cabral, et al.
Sleep|June 3, 2021
Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysisKaren A Matthews, Laisze Lee, Howard M Kravitz, et al.
Obstetrics and Gynecology|March 10, 2023
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled TrialGenevieve Neal-Perry, Antonio Cano, Samuel Lederman, et al.
Maturitas|April 30, 2018
Religiosity and faith in relation to time to metabolic syndrome for Hispanic women in a multiethnic cohort of women-Findings from the Study of Women's Health Across the Nation (SWAN)Amanda A Allshouse, Nanette Santoro, Robin Green, et al.
Menopause (New York, N.Y.)|December 4, 2019
Daily luteal serum and urinary hormone profiles in the menopause transition: Study of Women's Health Across the NationNanette Santoro, Samar R El Khoudary, Alexis Nasr, et al.
Environmental Epidemiology (Philadelphia, Pa.)|June 20, 2019
Ambient Air Pollution Exposure and Fecundability in Women Undergoing In Vitro FertilizationSabah M Quraishi, Paul C Lin, Kevin S Richter, et al.
Lancet (London, England)|March 16, 2023
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled studySamuel Lederman, Faith D Ottery, Antonio Cano, et al.
Pageof 7